1-8 of 8
Peter McSweeney, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Optimizing Checkpoint Blockade As a Treatment for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

Matthew S. Davids, MD, Haesook T Kim, PhD, Caitlin Costello, MD, Alex F. Herrera, MD, Frederick L. Locke, MD, Peter McSweeney, MD, Rodrigo O. Maegawa, MD, Alexandra Savell, BS, Michael Mazzeo, BA, David E. Avigan, MD, Yi-Bin Chen, MD, Nicole R. LeBoeuf, MD MPH, Vincent T Ho, MD, Corey S. Cutler, MD MPH, John Koreth, MBBS, DPhil, Edwin Alyea, III, MD, Joseph H. Antin, MD, Pavan Bachireddy, MD, Catherine J. Wu, MD, Jerome Ritz, MD, Howard Streicher, MD, Edward D Ball, MD, Asad Bashey, MD PhD, Philippe Armand, MD PhD, Robert J. Soiffer, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 275.
https://doi.org/10.1182/blood.V130.Suppl_1.275.275
Published: 2017
Journal Articles

Kte-C19 (anti-CD19 CAR T Cells) Induces Complete Remissions in Patients with Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Results from the Pivotal Phase 2 Zuma-1

Sattva S. Neelapu, MD, Frederick L. Locke, MD, Nancy L. Bartlett, MD, Lazaros Lekakis, MD, David Miklos, MD PhD, Caron A. Jacobson, MD, Ira Braunschweig, MD, Olalekan Oluwole, MBBS, MPH, Tanya Siddiqi, MD, Yi Lin, MD PhD, John Timmerman, MD, Patrick J. Stiff, Jonathan Friedberg, MD, Ian Flinn, Andre Goy, MD, Mitchell Smith, Abhinav Deol, MD, Umar Farooq, MD, Peter McSweeney, MD, Javier Munoz, MD, Irit Avivi, MD, Januario E. Castro, MD, Jason R. Westin, MD MS, Julio C. Chavez, MD, Armin Ghobadi, MD, Krishna V. Komanduri, MD, Ronald Levy, MD, Eric D. Jacobsen, Patrick Reagan, MD, Adrian Bot, MD PhD, John M. Rossi, MS, Lynn Navale, MS, Yizhou Jiang, PhD, Jeff S. Aycock, BA, Meg Elias, RN, BSN, Jeff Wiezorek, MD MS, William Y. Go, MD PhD
Journal: Blood
Blood (2016) 128 (22): LBA-6.
https://doi.org/10.1182/blood.V128.22.LBA-6.LBA-6
Published: 2016
Journal Articles

Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors

Mohamed L. Sorror, MD, MSc, Barry Storer, PhD, Brenda M. Sandmaier, MD, Georg N. Franke, MD, Ginna G. Laport, MD, Thomas Chauncey, MD, Edward Agura, MD, Michael T. Maris, MD, James Wade, MD, Michael A. Pulsipher, MD, Richard T Maziarz, MD, Firoozeh Sahebi, MS, Peter McSweeney, MD, Benedetto Bruno, MD, Lars indelov, V, MD, Andrew M. Yeager, MD, Andrew Rezvani, MD, Dietger W Niederwieser, MD, Karl G. Blume, MD, Rainer F. Storb, MD, David G. Maloney, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1292.
https://doi.org/10.1182/blood.V116.21.1292.1292
Published: 2010
Journal Articles

Relapse Risk after Nonmyeloablative Hematopoietic Cell Transplantation for Malignant Diseases.

Christoph Kahl, MD, Barry Storer, PhD, Marco Mielcarek, MD, Mike Maris, MD, Brenda Sandmaier, MD, David Maloney, MD, PhD, Thomas Chauncey, MD, Dietger Niederwieser, MD, Peter McSweeney, MD, Benedetto Bruno, MD, Karl Blume, MD, James Wade, MD, Jose Leis, MD, PhD, Emilia Langston, MD, Michael Pulsipher, MD, Edward Agura, MD, Rainer Storb, MD
Journal: Blood
Blood (2005) 106 (11): 703.
https://doi.org/10.1182/blood.V106.11.703.703
Published: 2005
Journal Articles

Preliminary Data on Once-Daily IV Busulfan at 3.2 mg/kg/day Indicate That It Is Safe as a Component of the Conditioning Regimen for Hematopoietic Stem Cell Transplantation.

Mark W. Brunvand, MD, Robert Rifkin, MD, Jeffry V. Matous, MD, Peter McSweeney, MD, Scott Bearman, MD
Journal: Blood
Blood (2004) 104 (11): 5033.
https://doi.org/10.1182/blood.V104.11.5033.5033
Published: 2004
Journal Articles

Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL).

Mohamed Sorror, MD, MSc, Michael Maris, MD, Barry Storer, PhD, Brenda Sandmaier, MD, Monic Stuart, MD, Ute Hegenbart, MD, Edward Agura, MD, Thomas Chauncey, MD, Jose Leis, MD, PhD, Michael Pulsipher, MD, Peter McSweeney, MD, Jerry Radich, MD, James Wade, MD, Benedetto Bruno, MD, Amelia Langston, MD, Dietger Niederwieser, MD, Karl Blume, MD, Rainer Storb, MD, David Maloney, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2323.
https://doi.org/10.1182/blood.V104.11.2323.2323
Published: 2004
Journal Articles

Treatment for Acute Myelogenous Leukemia by Low Dose Irradiation Based Conditioning and Hematopoietic Cell Transplantation from Related and Unrelated Donors.

Dietger W. Niederwieser, Ute Hegenbart, MD, Brenda M. Sandmaier, MD, Michael B. Maris, MD, Monic Stuart, MD, Hildegard Greinix, MD, Catherine Cordonnier, Bernard Rio, MD, Alois Gratwohl, Thoralf Lange, MD, Wolfram Pòˆnisch, MD, Leante Grommisch, MD, Barry Storer, MD, David Maloney, MD, Peter McSweeney, MD, Thomas Chauncey, MD, Ed Agura, MD, Karl Blume, Rainer Storb
Journal: Blood
Blood (2004) 104 (11): 3074.
https://doi.org/10.1182/blood.V104.11.3074.3074
Published: 2004
Journal Articles

High-Dose Immunosuppressive Therapy (HDIT) for Severe Systemic Sclerosis (SSc): Long-Term Survivors Show Continued Improvement of Function and Skin with Stability in the Lungs.

Peter McSweeney, MD, Daniel Furst, MD, Leslie Crofford, MD, Kevin McDonagh, MD, Keith Sullivan, MD, Mayes Maureen, MD, Nelson Lee, MD, Theodore Gooley, Ph.D., Jan Storek, MD, PhD, Leona Holmberg, MD, PhD, C.S. Chen, MD, PhD, Mark Wener, MD, Julie Lee, RN, Gretchen Henstorf, CCRC, Muneer Abidi, MD, Philip Mease, MD, Richard Nash, MD
Journal: Blood
Blood (2004) 104 (11): 149.
https://doi.org/10.1182/blood.V104.11.149.149
Published: 2004